Cleveland scientists say they may have found a way to keep the brain sharp even after punishing rounds of whole-brain ...

The Alzheimer’s drugs market is projected to grow at a compound annual growth rate (CAGR) of around 20% during the forecast period. This rapid expansion is primarily fueled by the rising prevalence of ...

These new drugs have transformed research into new therapies. There are more clinical trials in Alzheimer’s than ever before. Studies indicate other pathways besides the amyloid protein that ...

Alzheimer's disease (AD) is the most common neurodegenerative disorder, characterized by progressive cognitive decline and ...

Alzheimer disease (AD) is the most common cause of dementia and one of the leading causes of death in adults age 65 y or ...